Preferred Label : Alpha-1-Proteinase Inhibitor Human;
NCIt synonyms : A1AT; Alpha 1 Antitrypsin; Alpha-1 Antitrypsin; AAT; Alpha-1-Antiproteinase; A1PI;
NCIt related terms : .ALPHA.1-PROTEINASE INHIBITOR HUMAN; Glassia;
NCIt definition : Human serum-derived alpha-1 proteinase inhibitor (alpha-1-antitrypsin or AAT) with
immunomodulating and anti-inflammatory activity. Upon administration, AAT reduces
the production of proinflammatory cytokines, such as tumor necrosis factor-alpha,
interleukin (IL)-1 beta, IL-32, IL-6, and proteinase 3, and induces the production
of anti-inflammatory cytokines, such as IL-10 and the IL-1 receptor antagonist IL-1RN.
This agent also downregulates heparan sulfate and reduces the expansion of cytotoxic
effector T cells, interferes with the maturation of dendritic cells and increases
T regulatory cells. Altogether, AAT may attenuate acute graft-versus-host disease
(GvHD) and may facilitate graft acceptance and survival. In addition, AAT enhances
levels of cAMP and activation of cAMP-dependent protein kinase A. AAT, a 52kD protein
and serine protease inhibitor, belongs to the serpin superfamily.;
UNII : F43I396OIS;
CAS number : 9041-92-3;
Drug name : Aralast; Prolastin-C; Glassia;
Origin ID : C82258;
UMLS CUI : C0795657;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Semantic type(s)
UMLS correspondences (same concept)
concept_is_in_subset